Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Firm Gifts To Physicians To Be Studied By OIG In FY 2002

Executive Summary

Pharmaceutical company gifts and payments to physicians will be the subject of a study by the HHS Office of the Inspector General scheduled to be released in FY 2002.

You may also be interested in...



PhRMA & AMA address physician gifts

Pharmaceutical Research & Manufacturers of America and American Medical Association meeting the week of Jan. 14 included discussion of gifts for physicians, but no action items, AMA said. The two organizations meet yearly to discuss topics of common interest. An HHS Inspector General inquiry into physician gifts could trigger another round of political scrutiny of the topic (1"The Pink Sheet" Oct. 8, 2001, p. 5)...

PhRMA & AMA address physician gifts

Pharmaceutical Research & Manufacturers of America and American Medical Association meeting the week of Jan. 14 included discussion of gifts for physicians, but no action items, AMA said. The two organizations meet yearly to discuss topics of common interest. An HHS Inspector General inquiry into physician gifts could trigger another round of political scrutiny of the topic (1"The Pink Sheet" Oct. 8, 2001, p. 5)...

Gifts to physicians

HHS IG deletes one project from FY 2002 work plan: review of 1990 FDA regulations regarding gifts to physicians from pharmaceutical companies is unnecessary. FDA does not have regulations on gifts to physicians. The work plan was issued Oct. 1 (1"The Pink Sheet" Oct. 8, p. 5)...

UsernamePublicRestriction

Register

OM016204

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel